Biomarin Pharmaceutical Inc (LTS:0HNC)
$ 79.67 -0.86 (-1.07%) Market Cap: 15.12 Bil Enterprise Value: 15.17 Bil PE Ratio: 74.44 PB Ratio: 2.98 GF Score: 76/100

Biomarin Pharmaceutical Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Dec 01, 2021 / 06:25PM GMT
Release Date Price: $85.99 (-0.29%)
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

All right. Welcome, everyone. It's Josh Schimmer from Evercore ISI Biotech team with BioMarin. Yesterday after a really busy day at our conference, I was thinking the last thing I want to do is listen to a 3-hour R&D event from the company. But you can turn it on double speed and turn it into just 1.5 hours, and I thought it was excellent. As I really enjoyed listening to it. You covered a lot of ground and introduced some really compelling new programs. I'm going to vote this BioMarin's best R&D Day yet in terms of shifting my perception of the company.

Questions & Answers

Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

So I've jotted -- as I was taking notes, I was jotting down questions, there's not going to be like a great order to this. And aside from kind of following the presentations from yesterday, I'm going to start with the steroid prophylaxis commentary

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot